• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America

9780443181856
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
544.26 zł
462.62 zł Save 81.64 zł
Lowest price within 30 days before promotion: 462.62 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.
Product Details
Elsevier
94004
9780443181856
9780443181856

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • Disparities in Breast Cancer Outcomes and How to Resolve Them

    Testing for Inherited Susceptibility to Breast Cancer

    Breast Cancer Pathology in the Era of Genomics

    Breast Cancer Pathology in the Era of Genomics

    Role of Ovarian Suppression in Early Premenopausal Breast Cancer

    Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer

    Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer

    Biology and Treatment of HER2-Low Breast Cancer

    Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer

    Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer

    The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

    Multidisciplinary Management of Brain Metastasis from Breast Cancer

    Systemic Therapy for Hereditary Breast Cancers

    Evidence-Based Guidance for Breast Cancer Survivorship

Comments (0)